Read about Gufic BioSciences Ltd company details like share price, management, news and more at IIFL Capital.

Gilead announced a deal to get its groundbreaking HIV prevention drug to lower income countries. Notably, the deal does not ...

Praxis Precision Medicines (NASDAQ:PRAX – Get Free Report)‘s stock had its “buy” rating reissued by analysts at Needham & Company LLC in a research note issued to investors on Thursday ...

Vertex Pharmaceuticals said on Tuesday its next-generation cystic fibrosis treatment has won European Union approval for a ...

A blistering rally in a tiny, money-losing traditional Chinese medicine company’s stock has vaulted its founder’s net worth to among the world’s 100 largest fortunes. The firm, Hong Kong ...

Regencell Bioscience has soared nearly 60,000% year-to-date despite the company having no revenue. The Chinese herbal medicine company says it has a proprietary formula that can help treat ADHD ...

BOSTON & MONTREAL, June 12, 2025--enGene Holdings Inc. (Nasdaq: ENGN, or "enGene" or the "Company"), a clinical-stage, non-viral genetic medicines company, today announced its financial results ...

Regencell Bioscience has soared nearly 60,000% year-to-date despite the company having no revenue. The Chinese herbal medicine company says it has a proprietary formula that can help treat ADHD and ...

REDWOOD CITY, Calif. - Revolution Medicines, Inc. (NASDAQ:RVMD), a $7.46 billion market cap biotechnology company, has secured a $2 billion flexible funding agreement with Royalty Pharma to ...

Some new medications in development are also trying to solve for a persistent side effect of existing drugs: Patients who ...

/PRNewswire/ -- SpliceBio, a clinical-stage genetic medicines company pioneering Protein Splicing to address diseases caused by mutations in large genes, today ...